Sensible advice for aches, pains & injuries
bibliography * The PainScience Bibliography contains plain language summaries of thousands of scientific papers and others sources, like a specialized blog. This page is about a single scientific paper in the bibliography, Brady 2014.

The side effects of dry needling of sore spots are probably worse than proponents realize

Brady S, McEvoy J, Dommerholt J, Doody C. Adverse events following trigger point dry needling: a prospective survey of chartered physiotherapists. J Man Manip Ther. 2014 Aug;22(3):134–40. PubMed #25125935.
Tags: treatment, dry needling, harms, muscle pain, muscle, pain problems

PainSci summary of Brady 2014?This page is one of thousands in the bibliography. It is not a general article: it is focused on a single scientific paper, and it may provide only just enough context for the summary to make sense. Links to other papers and more general information are provided at the bottom of the page, as often as possible. ★★☆☆☆?2-star ratings are for studies with flaws, bias, and/or conflict of interest; published in lesser journals. Ratings are a highly subjective opinion, and subject to revision at any time. If you think this paper has been incorrectly rated, please let me know.

Lancing sore spots with acupuncture needles — trigger point dry needling — is a common treatment, with many critics concerned about its efficacy and safety.

This study surveyed several dozen physiotherapists trained in dry needling, and that is a huge unacknowledged weakness of the study: if you want to know about things that go wrong with treatments, you need to ask patients. The professionals delivering the service are clearly going to be biased and unaware of many problems that patients don’t report, and they might even fail to report problems they do know about. And indeed, “no significant adverse events” were reported! And that hardly seems surprising, given that they were basically asking professionals to incriminate themselves, to reveal serious consequences of their treatments. The only discussion of this limitation in the paper is this sentence: “Participants [physiotherapists] may have been reluctant to report events where negligence could be inferred, as participants were potentially identifiable.” Understatement.

The lack of acknowledgement of this problem probably indicates the bias of the researchers themselves, who clearly have a dog in this fight: they are pro-needling.

So I do not trust the results, and assume the truth is worse than what’s being reported here. And so what is being reported here? Mild problems with about 20% of all treatments, mainly bruising (7.5%) and bleeding (4.6%) and pain during and after treatment (2-3%). Some uncommon, sub-1% adverse effects included aggravation of symptoms, headache, nausea, shaking, itching, and numbness.

“Aggravation of symptoms” is one the most important considerations from the patient perspective (and the least likely to be known/reported by practitioners). It’s one thing to risk a “side” effect, which may come with compensating benefits, and quite another to risk a direct backfire. When the symptoms you’re trying to treat get worse instead of better, that’s a much worse deal than, say, getting relief from your symptoms at the cost of some bruising and bleeding. This survey reported a rate of .88% of symptom aggravation, and I think the truth might be much worse.

~ Paul Ingraham

original abstractAbstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.

OBJECTIVES: Trigger point dry needling (TrP-DN) is commonly used to treat persons with myofascial pain, but no studies currently exist investigating its safety. The aim of this study was to determine the incidence of Adverse Events (AEs) associated with the use of TrP-DN by a sample of physiotherapists in Ireland.

METHODS: A prospective survey was undertaken consisting of two forms recording mild and significant AEs. Physiotherapists who had completed TrP-DN training with the David G Simons Academy (DGSA) were eligible to take part in the study. Data were collected over a ten-month period.

RESULTS: In the study, 39 physiotherapists participated and 1463 (19.18%) mild AEs were reported in 7629 treatments with TrP-DN. No significant AEs were reported giving an estimated upper risk rate for significant AEs of less than or equal to (≤) 0.04%. Common AEs included bruising (7.55%), bleeding (4.65%), pain during treatment (3.01%), and pain after treatment (2.19%). Uncommon AEs were aggravation of symptoms (0.88%), drowsiness (0.26%), headache (0.14%), and nausea (0.13%). Rare AEs were fatigue (0.04%), altered emotions (0.04%), shaking, itching, claustrophobia, and numbness, all 0.01%.

DISCUSSION: While mild AEs were very commonly reported in this study of TrP-DN, no significant AEs occurred. For the physiotherapists surveyed, TrP-DN appeared to be a safe treatment.

related content

These two articles on cite Brady 2014 as a source:

This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights: